-Ikuo Sekine Researcher Activity Profile

Research Author Detailed Information 

Ikuo Sekine Publication Rate By Year

Ikuo Sekine has published 1 paper(s) in 1990, 15 paper(s) in 2007, 9 paper(s) in 2008, for a total of 25 research publications in total.

Ikuo I Sekine Author Information

LAST NAME: sekine

FIRST NAME: Ikuo

INITIALS: i

AFFILIATION:

Papers

Ikuo Sekine's Publication Record

1. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer. Year Published: 2007
Divisions of Thoracic Oncology and Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
2. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
3. Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
4. Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan.
5. Genes regulating the sensitivity of solid tumor cell lines to cytotoxic agents: a literature review. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
6. Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Year Published: 2007
Divisions of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
7. Expression of Angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannoma. Year Published: 2007
Department of Tumor and Diagnostic Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, Japan. toshi-n@nagasaki-u.ac.jp
8. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
9. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
10. Incidence of multiple primary cancers in Nagasaki atomic bomb survivors: association with radiation exposure. Year Published: 2007
Tissue and Histopathology Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Medicine, Nagasaki 851-8523, Japan. moemoe@nagasaki-u.ac.jp
11. Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences.
12. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis. Year Published: 2008
Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. moemoe@nagasaki-u.ac.jp
13. Expression of angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannoma. Year Published: 2007
Department of Tumor and Diagnostic Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, Japan. toshi-n@nagasaki-u.ac.jp
14. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
15. The role of the sympathetic nervous system in cysteamine-induced gastric lesions in rats. Year Published: 1990
Department of Pathology, Nagasaki University School of Medicine, Japan.
16. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
17. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis. Year Published: 2008
Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. moemoe@nagasaki-u.ac.jp
18. Incidence of multiple primary cancers in Nagasaki atomic bomb survivors: association with radiation exposure. Year Published: 2007
Tissue and Histopathology Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Medicine, Nagasaki 851-8523, Japan. moemoe@nagasaki-u.ac.jp
19. Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer. Year Published: 2008
1Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
20. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling. Year Published: 2008
Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
21. Influence of Previous Chemotherapy on the Efficacy of Subsequent Docetaxel Therapy in Advanced Non-small Cell Lung Cancer Patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
22. Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
23. Alteration of p53-binding protein 1 expression during skin carcinogenesis: Association with genomic instability. Year Published: 2008
Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki Unviersity Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
24. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability. Year Published: 2008
Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki Unviersity Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
25. Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp